Zinc-binding of endostatin is essential for its antiangiogenic activity

被引:112
作者
Boehm, T
O'Reilly, MS
Keough, K
Shiloach, J
Shapiro, R
Folkman, J
机构
[1] Childrens Hosp, Dept Surg, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA
[3] Harvard Univ, Sch Med, Dept Cellular Biol, Boston, MA 02115 USA
[4] NIDDKD, Biotechnol Unit, Bethesda, MD 20892 USA
[5] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Ctr Biochem & Biophys Sci & Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1006/bbrc.1998.9617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endostatin is a potent angiogenesis inhibitor in vitro and in vivo. We used the yeast Pichia pastoris to express and purify soluble endostatin. It was discovered that metal chelating agents can induce N-terminal degradation of endostatin. We theorized that a metal was removed from endostatin which changed the conformation and allowed a contaminating protease to degrade the N-terminus. Atomic absorption and amino acid analysis of endostatin purified from Pichia pastoris and mammalian cells showed a 1:1 molar ratio of Zn2+ to protein. Ding et at have shown that histidines 1, 3, 11, and aspartic acid 76 coordinate the Zn2+ atom (1). An H1/3A double, an H11A, and a D76A single mutant of endostatin were not able to regress Lewis lung carcinoma. We conclude that the ability of endostatin to bind Zn2+ is essential for its antiangiogenic activity. (C) 1998 Academic Press.
引用
收藏
页码:190 / 194
页数:5
相关论文
共 13 条
[1]   The galvanization of biology: A growing appreciation for the roles of zinc [J].
Berg, JM ;
Shi, YG .
SCIENCE, 1996, 271 (5252) :1081-1085
[2]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[3]   ZINC PROTEINS - ENZYMES, STORAGE PROTEINS, TRANSCRIPTION FACTORS, AND REPLICATION PROTEINS [J].
COLEMAN, JE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :897-946
[4]   DIMERIZATION OF HUMAN GROWTH-HORMONE BY ZINC [J].
CUNNINGHAM, BC ;
MULKERRIN, MG ;
WELLS, JA .
SCIENCE, 1991, 253 (5019) :545-548
[5]   ZINC MEDIATION OF THE BINDING OF HUMAN GROWTH-HORMONE TO THE HUMAN PROLACTIN RECEPTOR [J].
CUNNINGHAM, BC ;
BASS, S ;
FUH, G ;
WELLS, JA .
SCIENCE, 1990, 250 (4988) :1709-1712
[6]   Zinc-dependent dimers observed in crystals of human endostatin [J].
Ding, YH ;
Javaherian, K ;
Lo, KM ;
Chopra, R ;
Boehm, T ;
Lanciotti, J ;
Harris, BA ;
Li, Y ;
Shapiro, R ;
Hohenester, E ;
Timpl, R ;
Folkman, J ;
Wiley, DC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10443-10448
[7]  
FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
[8]   Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution [J].
Hohenester, E ;
Sasaki, T ;
Olsen, BR ;
Timpl, R .
EMBO JOURNAL, 1998, 17 (06) :1656-1664
[9]   Angiostatin induces and sustains dormancy of human primary tumors in mice [J].
OReilly, MS ;
Holmgren, L ;
Chen, C ;
Folkman, J .
NATURE MEDICINE, 1996, 2 (06) :689-692
[10]   ANGIOSTATIN - A NOVEL ANGIOGENESIS INHIBITOR THAT MEDIATES THE SUPPRESSION OF METASTASES BY A LEWIS LUNG-CARCINOMA [J].
OREILLY, MS ;
HOLMGREN, L ;
SHING, Y ;
CHEN, C ;
ROSENTHAL, RA ;
MOSES, M ;
LANE, WS ;
CAO, YH ;
SAGE, EH ;
FOLKMAN, J .
CELL, 1994, 79 (02) :315-328